查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2016574

梅毒检测市场：按类型、地点和地区划分（2026-2034 年）

Syphilis Testing Market by Type (Primary and Secondary Syphilis, Latent and Tertiary Syphilis), Location of Testing (Laboratory Testing, Point-of-Care (POC) Testing), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2025年全球梅毒检测市场规模达13.4亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到20.7亿美元，2026年至2034年的复合年增长率为4.82% 。性行为感染感染（STI）的流行、流产率的上升以及医疗保健行业对有效疾病诊断和检测解决方案日益增长的需求是推动该市场发展的主要因素。

梅毒是一种性行为感染感染（STI），通常由性接触引起，并透过皮肤或黏膜接触传播。初期症状包括生殖器、直肠或口腔出现无痛性溃疡。如不及时治疗，可发展为第三期併发症，损害脑部、神经、血管及关节。快速血浆反应素试验（RPR）和性病实验室检测（VDRL）现已成为医疗专业人员常用的标准检测方法。这些方法有助于早期发现梅毒，从而进行更恰当的治疗，并性行为感染传染病（STI）的传播和进展。因此，梅毒检测在检查室和即时检测（PoC）中心被广泛用于诊断梅毒类型并确定合适的治疗方法。

梅毒检测市场趋势：

性行为感染(STI) 治疗的认识不断提高，是推动市场成长的主要因素。因此，各国政府和各类非政府组织 (NGO) 正积极进行宣传活动，提高民众对性行为感染预防和现有治疗方法（包括梅毒）的认识。这促进了快速梅毒试纸等检测套组的普及，从而推动了市场成长。这些试剂盒可在家中进行准确诊断，帮助人们快速做出决策，进而促进市场成长。此外，这些试剂盒使用方便，价格实惠，且在网路零售商和实体药局均有销售，这也是推动市场成长的原因之一。同时，医学领域的重大进步以及旨在将有效治疗方法推向市场的最新研发活动也对市场成长产生了积极影响。最后，有利于性行为感染检测的医疗报销政策也促进了市场成长。其他促成市场前景乐观的因素包括：性行为感染（包括梅毒）的盛行率不断上升；无保护性行为的发生率不断增加；有效筛检方案的广泛实施；以及对疾病早期诊断的日益重视。

本报告解答的主要问题

  • 全球梅毒检测市场迄今为止的发展趋势是什么？您认为未来几年它将如何发展？
  • 全球梅毒检测市场的驱动因素、阻碍因素和机会是什么？
  • 主要区域市场有哪些？
  • 哪个国家的梅毒检测市场最具吸引力？
  • 按类型分類的市场组成是什么？
  • 依施行地点，市场区隔如何？
  • 全球梅毒检测市场的竞争格局如何？
  • 全球梅毒检测市场的主要参与者/公司有哪些？

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球梅毒检测市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依类型

  • 一期梅毒和二期梅毒
  • 潜伏性梅毒和第三期梅毒

第七章 市场区隔：依施行地点

  • 检查室检测
  • 即时侦测 (POC)

第八章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章：促进、抑制与机会

第十章：价值链分析

第十一章：波特五力分析

第十二章：价格分析

第十三章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • DRG International Inc.（BioCheck Inc.）
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers AG（Siemens AG）
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A6876

The global syphilis testing market size reached USD 1.34 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.07 Billion by 2034, exhibiting a growth rate (CAGR) of 4.82% during 2026-2034. The growing prevalence of sexually transmitted diseases (STDs), the increasing incidences of miscarriages, and the rising need for effective disease diagnosing and testing solutions in the healthcare sector represent some of the key factors driving the market.

Syphilis refers to a sexually transmitted infection (STI) that is usually caused by sexual contact and is spread amongst individuals through the skin or mucous membrane contact. It starts as a painless sore on the genitals and rectum of the mouth. If left untreated, it might trigger complications of tertiary syphilis, wherein the disease may damage the brain, nerves, blood vessels, and joints. At present, rapid plasma reagin (RPR) and venereal diseases research laboratory (VDRL) are standard testing practices that are being used by practitioners. These approaches provide early detection for better treatment and mitigate the spread and development of sexually transmitted diseases (STDs). As a result, syphilis testing is frequently used in laboratories and point-of-care (PoC) centers to diagnose the syphilis type and identify its proper treatment.

SYPHILIS TESTING MARKET TRENDS:

The increasing awareness regarding STD treatment represents one of the key factors driving the market growth. In line with this, governments of various nations, along with different non-governmental organizations (NGOs) are actively undertaking campaigns to sensitize the common mass regarding the prevention of STDs, including syphilis, and the available treatment options. This, in turn, is facilitating the adoption of syphilis testing kits, such as syphilis rapid test strips, which is favorably supporting the market growth. These kits offer at-home testing with effective diagnostic results, and thus timely decision-making, which is also contributing to the market growth. Additionally, the convenience of usage and the easy availability of these test kits at online retail stores and in-store pharmacies at affordable price points are contributing to the market growth. Apart from this, the considerable improvements in the healthcare sector and the recent research and development (R&D) activities to launch effective treatment alternatives are positively impacting the market growth. Moreover, the presence of favorable medical reimbursement policies for the testing of sexually transmitted infections is contributing to the market growth. Other factors, such as the increasing prevalence of STDs, including syphilis, rising incidences of unprotected sexual intercourse, the widespread implementation of effective screening programs, and an enhanced focus on the early diagnostic of the disease, are creating a positive outlook for the market.

KEY MARKET SEGMENTATION:

Type Insights:

  • Primary and Secondary Syphilis
  • Latent and Tertiary Syphilis

The report has also provided a detailed breakup and analysis of the syphilis testing market based on the type. This includes primary and secondary, and latent and tertiary syphilis. According to the report, primary and secondary syphilis represented the largest segment.

Location of Testing Insights:

  • Laboratory Testing
  • Point-of-Care (POC) Testing

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for syphilis testing. Some of the factors driving the North America syphilis testing market included the increasing prevalence of STDs, significant technological advancements, and extensive research and development (R&D) activities.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global syphilis testing market. Detailed profiles of all major companies have also been provided. Some of the companies covered includes Abbott Laboratories, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, DRG International Inc. (BioCheck Inc.), F. Hoffmann-La Roche AG, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global syphilis testing market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global syphilis testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive syphilis testing markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the location of testing?
  • What is the competitive structure of the global syphilis testing market?
  • Who are the key players/companies in the global syphilis testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Syphilis Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Primary and Secondary Syphilis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Latent and Tertiary Syphilis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Location of Testing

  • 7.1 Laboratory Testing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Point-of-Care (POC) Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Becton Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bio-Rad Laboratories Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Danaher Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 DRG International Inc. (BioCheck Inc.)
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 F. Hoffmann-La Roche AG
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Siemens Healthineers AG (Siemens AG)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Thermo Fisher Scientific Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Syphilis Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Syphilis Testing Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Syphilis Testing Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Syphilis Testing Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Syphilis Testing Market: Breakup by Location of Testing (in %), 2025
  • Figure 6: Global: Syphilis Testing Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Syphilis Testing (Primary and Secondary Syphilis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Syphilis Testing (Primary and Secondary Syphilis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Syphilis Testing (Latent and Tertiary Syphilis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Syphilis Testing (Latent and Tertiary Syphilis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Syphilis Testing (Laboratory Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Syphilis Testing (Laboratory Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Syphilis Testing (Point-of-Care (POC) Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Syphilis Testing (Point-of-Care (POC) Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: North America: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: North America: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: United States: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: United States: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Canada: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Canada: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Asia-Pacific: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Asia-Pacific: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: China: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: China: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Japan: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Japan: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: India: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: India: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: South Korea: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: South Korea: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Australia: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Australia: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Indonesia: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Indonesia: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Others: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Others: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Europe: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Europe: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Germany: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Germany: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: France: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: France: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: United Kingdom: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: United Kingdom: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Italy: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Italy: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Spain: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Spain: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Russia: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Russia: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Latin America: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Latin America: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Brazil: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Brazil: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Mexico: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Mexico: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Others: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Others: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Middle East and Africa: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Middle East and Africa: Syphilis Testing Market: Breakup by Country (in %), 2025
  • Figure 63: Middle East and Africa: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Global: Syphilis Testing Industry: Drivers, Restraints, and Opportunities
  • Figure 65: Global: Syphilis Testing Industry: Value Chain Analysis
  • Figure 66: Global: Syphilis Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Syphilis Testing Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Syphilis Testing Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Syphilis Testing Market Forecast: Breakup by Location of Testing (in Million USD), 2026-2034
  • Table 4: Global: Syphilis Testing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Syphilis Testing Market: Competitive Structure
  • Table 6: Global: Syphilis Testing Market: Key Players